Major depressive disorder, antidepressants and sexual dysfunction;Depression und antidepressiva: Auswirkungen auf die sexualität

Neuropsychiatrie

Volumn 23, Issue 2, 2009, Pages 134-138

  Kinzl, Johann F ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Dept für Psychiatrie und Psychotherapie   (Germany)

Author keywords

Antidepressants; Depressive disorder; Sexual dysfunction

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; MOCLOBEMIDE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ARTICLE; HUMAN; MAJOR DEPRESSION; MALE SEXUAL DYSFUNCTION; MENTAL PATIENT; MOOD; PATIENT COMPLIANCE; PREMATURE EJACULATION; QUALITY OF LIFE; SELF ESTEEM; SEXUAL DYSFUNCTION; SEXUALITY;

AFFECT; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER, MAJOR; ERECTILE DYSFUNCTION; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; QUALITY OF LIFE; SELF CONCEPT; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 67650678443     PISSN: 09486259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. American Psychiatric Association: Diagnostisches und Statistisches Manual Psychischer Störungen - Textrevision - DSM-IV-TR. Hogrefe, Göttingen (2003)
2. Baldwin D.S.: Depression and sexual function. J Psychopharmacol 10 (Suppl 1), 30-34 (1996)
3. Baldwin D.S., Reines E.H., Guiton C., Weiller E.: Escitalopram therapy for major depression and anxiety disorders. Ann Pharmacother 41, 1583-1592 (2007) (Pubitemid 47485624)
4. Beier K.M., Loewit K.: Lust in Beziehungen. Springer, Berlin 2004
5. Clayton A.H.: Recognition and assessment of sexual dysfunction associated with depression. J Clin Psychiatry 62 (Suppl 3), 5-9 (2001)
6. Clayton A.H., Montejo A.L.: Major depressive disorder, antidepressants, and sexual dysfunction. J Clin Psychiatry 67 (Suppl 6), 33-37 (2006) (Pubitemid 44078111)
7. Clayton A., Croft H.A., Horrigan J.P. et al: Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 67, 736-746 (2006) (Pubitemid 43946180)
8. Clayton A., Kornstein S., Prakash A., Mallinckrodt C., Wohlreich M.: Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 4, 917-929 (2007) (Pubitemid 47082256)
9. Cohen S., Kühn K.U., Bender S., et al: Sexual impairment in psychiatric inpatients: focus on depression. Pharmacopsychiatry 40, 58-63 (2007) (Pubitemid 46697676)
10. Delgado P.L., Brannan S.K., Mallinckrodt C.H. et al: Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 66, 686-692 (2005) (Pubitemid 40942413)
11. Fava M., Nurnberg H.G., Seidman S.N. et al: Efficacy and safety of sildenafil in men with serotonergic antdepressantassociated erectile dysfunction: results from a randomized, double-blind, placebo- controlled trial. J Clin Psychiatry 67, 240-246 (2006) (Pubitemid 43357470)
12. Gelenberg A.J., McGahuey C., Laukes C. et al: Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry 62, 356-360 (2000) (Pubitemid 30345937)
13. Gorman J.M., Kent J.M.: SSRIs and SNRIs: broad spectrum of efficacy beyond major depression. J Clin Psychiatry 60 (Suppl 4), 33-38 (1999) (Pubitemid 29143099)
14. Kockott G., Fahrner E.M.: Sexuelle Funktionsstörungen. Thieme, Stuttgart - New York 2004
15. Michelson D., Bancroft J., Targum S., Kim Y., Tepner R.: Female sexual dysfunction associated with antidepressant administration: a randomized, placebocontrolled study of pharmacologic intervention. Am J Psychiatry 157, 239-243 (2000) (Pubitemid 30080904)
16. Montejo-Gonzales A.L., Llorca G., Izquierdo J.A., Rico-Villademoros F.: Incidence of sexual dysfunction associated with antdepressant agents: a prospective multicenter, study of 1022 outpatients. J Clin Psychiatry 62 (Suppl 3), 10-21 (2001) (Pubitemid 32164676)
17. Osvath P., Fekete S., Vörös V, Almasi J.: Changes in sexual function in mirtazapine treatment. Primary data of a national, multicenter, prospective observational study in depressed patients. Neuropsychopharmacol Hung 7, 177-186 (2005)
18. Piazza L.A., Markowitz J.C., Kocsis J.H. et al: Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study. Am J Psychiatry 154, 1757-1759 (1997) (Pubitemid 27516597)
19. Rothschild A.J.: Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 152, 1514-1516 (1995)
20. Segraves R.T.: Antidepressant-induced sexual dysfunction. J Clin Psychiatry 59 (Suppl 4), 48-54 (1998)
21. Sigusch V.: Organogenese sexueller Funktionsstörungen. In: V. Sigusch (Hrsg.) Sexuelle Störungen und ihre Behandlung. (S. 125-144). Thieme, Stuttgart - New York 2007
22. Williams V.S., Baldwin D.S., Hogue S.L. et al: Estmating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry 67, 204-210 (2006) (Pubitemid 43357465)
23. Zajecka J.: Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin Psychiatry 62 (suppl 3), 35-43 (2001)